Why you can't compare Covid-19 vaccines
-
0:01 - 0:06This is the new one-dose Covid-19 vaccine
from Johnson & Johnson. -
0:06 - 0:09In early March,
more than 6,000 doses -
0:09 - 0:13were supposed to be shipped
to the city of Detroit, Michigan -
0:13 - 0:15but the mayor said, "No thanks".
-
0:15 - 0:18"Moderna and Pfizer are the best.
-
0:18 - 0:20And I am going to do
everything I can -
0:20 - 0:24to make sure the residents
of the city of Detroit get the best." -
0:24 - 0:29He was referring to these numbers:
the vaccines’ "efficacy rates." -
0:29 - 0:32The vaccines from Pfizer/BioNTech
and Moderna -
0:32 - 0:34have super high efficacy rates:
-
0:34 - 0:3795% and 94%.
-
0:37 - 0:39But Johnson & Johnson?
-
0:39 - 0:41Just 66%.
-
0:41 - 0:46And if you only look at these numbers,
it’s natural to think that these vaccines -
0:46 - 0:48are worse than these.
-
0:48 - 0:50But that assumption is wrong.
-
0:50 - 0:54These numbers are arguably
not even the most important measure -
0:54 - 0:57of how effective these vaccines are.
-
0:57 - 0:58To understand what is,
-
0:58 - 1:02you first have to understand
what vaccines are even supposed to do. -
1:06 - 1:11A vaccine’s efficacy rate
is calculated in large clinical trials, -
1:11 - 1:15when the vaccine is tested
on tens of thousands of people. -
1:15 - 1:17Those people are broken into two groups:
-
1:17 - 1:21half get the vaccine,
and half get a placebo. -
1:21 - 1:23Then, they’re sent out
to live their lives, -
1:23 - 1:28while scientists monitor whether or not
they get Covid-19 over several months. -
1:28 - 1:34In the trial for Pfizer/BioNTech, for
example, there were 43,000 participants. -
1:34 - 1:39In the end, 170 people
were infected with Covid-19. -
1:39 - 1:42And how those people fall
into each of these groups -
1:42 - 1:45determines a vaccine’s efficacy.
-
1:45 - 1:48If the 170 were evenly split,
-
1:48 - 1:51that would mean you’re just as likely
to get sick with the vaccine -
1:51 - 1:52as without it.
-
1:52 - 1:56So it would have a 0% efficacy.
-
1:56 - 2:02If all 170 were in the placebo group, and
zero people who got the vaccine were sick, -
2:02 - 2:06the vaccine would have
an efficacy of 100%. -
2:06 - 2:10With this particular trial,
there were 162 in the placebo group, -
2:10 - 2:12and just eight
in the vaccine group. -
2:12 - 2:18It means those who had the vaccine
were 95% less likely to get Covid-19: -
2:18 - 2:22The vaccine had a 95% efficacy.
-
2:23 - 2:29Now, this doesn’t mean that if 100 people
are vaccinated, 5 of them will get sick. -
2:29 - 2:34Instead, that 95% number
applies to the individual. -
2:34 - 2:35So each vaccinated person
-
2:35 - 2:41is 95% less likely than a person
without a vaccine to get sick -
2:41 - 2:44each time they’re exposed to Covid-19.
-
2:44 - 2:49And every vaccine’s efficacy rate
is calculated in the same way. -
2:49 - 2:55But each vaccine’s trial might be done in
very different circumstances. -
2:55 - 2:58So, one of the biggest
considerations here, -
2:58 - 2:59when we look at these numbers,
-
2:59 - 3:03is the timing in which
these clinical trials were performed. -
3:03 - 3:09This is the number of daily Covid-19 cases
in the US since the pandemic began. -
3:09 - 3:14The Moderna trial was done
completely in the US, here, in the summer. -
3:14 - 3:17The Pfizer/BioNTech trial was primarily
based in the US, too, -
3:17 - 3:20and at the same time.
-
3:20 - 3:25Johnson & Johnson, however,
held their US trial at this time, -
3:25 - 3:26when there were more opportunities
-
3:26 - 3:30for participants
to be exposed to infections. -
3:30 - 3:33And most of their trial took place
in other countries, -
3:33 - 3:36primarily South Africa and Brazil.
-
3:36 - 3:40And in these other countries,
not only were case rates high, -
3:40 - 3:43but the virus itself was different.
-
3:43 - 3:47The trials took place
as variants of Covid-19 emerged, -
3:47 - 3:50and became the dominant infections
in these countries; -
3:50 - 3:54variants that are more likely
to get participants sick. -
3:54 - 3:59In South Africa, most of the cases in the
Johnson & Johnson trial were that of the -
3:59 - 4:03variant, not the original strain that was
in the US over the summer. -
4:03 - 4:09And despite that, it still
significantly reduced infections. -
4:09 - 4:12"If you're trying to make one-to-one
comparisons between vaccines, -
4:12 - 4:16they need to have been studied in the same
trial, with identical inclusion criteria, -
4:16 - 4:19in the same parts of the world,
at the same time." -
4:19 - 4:22"If we were to take
Pfizer and Moderna's vaccines and -
4:22 - 4:27redo their clinical trial at the same time
that we saw J&J's clinical trial, -
4:27 - 4:31we might see quite different
efficacy numbers for those." -
4:31 - 4:36These efficacy numbers just tell you
what happened in each vaccine’s trial, -
4:36 - 4:39not exactly what will happen
in the real world. -
4:39 - 4:45But many experts argue this isn’t even the
best number to judge a vaccine by anyway. -
4:45 - 4:49Because preventing any infection at all is
not always the point of a vaccine. -
4:49 - 4:54"The goal of a Covid-19 vaccine program
is not really to get to 'Covid zero', -
4:54 - 4:57but it's to tame this virus, to defang it,
-
4:57 - 5:01to remove its ability to cause serious
disease, hospitalization, and death." -
5:01 - 5:06It helps to look at the different outcomes
of an exposure to Covid-19 like this: -
5:06 - 5:09The best-case scenario
is, you don’t get sick at all. -
5:09 - 5:12The worst case is death.
-
5:12 - 5:15In between, there’s being hospitalized,
severe-to-moderate symptoms, -
5:15 - 5:18or having no symptoms at all.
-
5:18 - 5:24In the best circumstances, vaccines
give you protection all the way to here. -
5:24 - 5:30But realistically, that isn’t the
main objective of the Covid-19 vaccines. -
5:30 - 5:35The real purpose is to give your body enough
protection to cover these possibilities, -
5:35 - 5:39so if you do get an infection,
it feels more like a cold -
5:39 - 5:42than something you'd be
hospitalized for. -
5:42 - 5:47And this is one thing that every one
of these Covid-19 vaccines do well. -
5:47 - 5:52In all these trials, while some people in
the placebo groups were hospitalized, -
5:52 - 5:54or even died from Covid-19,
-
5:54 - 5:59not one fully vaccinated person,
in any of these trials, -
5:59 - 6:02was hospitalized or died from Covid-19.
-
6:02 - 6:04"One thing I wish that mayor
would have understood -
6:04 - 6:11was that all three vaccines have essentially
100% effective in protecting from death." -
6:11 - 6:16The mayor of Detroit did backtracked and said
he’d start taking Johnson & Johnson doses, -
6:16 - 6:21because it’s still "highly effective
against what we care about most." -
6:21 - 6:25Efficacy matters.
But it doesn’t matter the most. -
6:25 - 6:30The question isn’t which vaccine will
protect you from any Covid infection, -
6:30 - 6:32but which one will keep you alive?
-
6:32 - 6:34Or out of the hospital?
-
6:34 - 6:36Which one will help end the pandemic?
-
6:36 - 6:38And that’s any of them.
-
6:38 - 6:42"The best vaccine right now for you
is the one that you're offered." -
6:42 - 6:46"With each shot that goes into someone arms,
we get closer to the end of this pandemic."
- Title:
- Why you can't compare Covid-19 vaccines
- Description:
-
What a vaccine's "efficacy rate" actually means.
Sign up for our newsletter: http://www.vox.com/video-newsletter
In the US, the first two available Covid-19 vaccines were the ones from Pfizer/BioNTech and Moderna. Both vaccines have very high "efficacy rates," of around 95%. But the third vaccine introduced in the US, from Johnson & Johnson, has a considerably lower efficacy rate: just 66%.
Look at those numbers next to each other, and it's natural to conclude that one of them is considerably worse. Why settle for 66% when you can have 95%? But that isn't the right way to understand a vaccine's efficacy rate, or even to understand what a vaccine does. And public health experts say that if you really want to know which vaccine is the best one, efficacy isn't actually the most important number at all.
Further reading from Vox:
Why comparing Covid-19 vaccine efficacy numbers can be misleading: https://www.vox.com/22311625/covid-19-vaccine-efficacy-johnson-moderna-pfizer
The vaccine metric that matters more than efficacy: https://www.vox.com/22273502/covid-vaccines-pfizer-moderna-johnson-astrazeneca-efficacy-deaths
The limits of what vaccine efficacy numbers can tell us: https://www.vox.com/21575420/oxford-moderna-pfizer-covid-19-vaccine-trial-biontech-astrazeneca-results
Vox.com is a news website that helps you cut through the noise and understand what's really driving the events in the headlines. Check out http://www.vox.com.
Watch our full video catalog: http://goo.gl/IZONyE
Follow Vox on Facebook: http://goo.gl/U2g06o
Or Twitter: http://goo.gl/XFrZ5H - Video Language:
- English
- Team:
- Amplifying Voices
- Project:
- COVID-19 Pandemic
- Duration:
- 07:02
ary nuansa edited English subtitles for Why you can't compare Covid-19 vaccines | ||
Sofia Angarita edited English subtitles for Why you can't compare Covid-19 vaccines | ||
Sofia Angarita edited English subtitles for Why you can't compare Covid-19 vaccines | ||
Jenny_PM edited English subtitles for Why you can't compare Covid-19 vaccines | ||
Jenny_PM edited English subtitles for Why you can't compare Covid-19 vaccines | ||
Jenny_PM edited English subtitles for Why you can't compare Covid-19 vaccines | ||
Jenny_PM edited English subtitles for Why you can't compare Covid-19 vaccines |